Home › Cancro al seno › California › Mountain View
Studi clinici su Cancro al seno a Mountain View, CA
26 studi su Cancro al seno cercano partecipanti presso sedi a Mountain View e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
In reclutamentoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
A Study of PHST001 in Advanced Solid Tumors
In reclutamentoFase 1
- Stanford University School of Medicine, Palo Alto · a 5 mi di distanza
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
In reclutamentoFase 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
In reclutamentoFase 1/2
- Stanford Medicine Cancer Center, Stanford · a 5 mi di distanza
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
In reclutamentoFase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- Stanford University Medical Center, Stanford · a 5 mi di distanza
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
In reclutamentoFase 1
- Stanford University Medical Center, Stanford · a 5 mi di distanza
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
In reclutamentoFase 3
- Stanford Cancer Center, Palo Alto · a 5 mi di distanza
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
In reclutamentoFase 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
In reclutamentoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
In reclutamentoFase 1
- Stanford University Hospital, Stanford · a 5 mi di distanza
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
In reclutamentoFase 3
- Research Site, Palo Alto · a 5 mi di distanza
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
In reclutamentoFase 2
- Stanford Cancer Institute, Palo Alto · a 5 mi di distanza
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
In reclutamentoFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · a 5 mi di distanza
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
In reclutamentoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · a 5 mi di distanza
- e altri 1
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
In reclutamentoFase 2
- Stanford University, Stanford · a 5 mi di distanza
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
In reclutamentoFase 2/3
- Local Institution - 0358, Stanford · a 5 mi di distanza
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
In reclutamentoFase 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · a 5 mi di distanza
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
In reclutamentoFase 1
- Stanford University Medical Center, Palo Alto · a 5 mi di distanza
Magnetic Resonance Imaging of Breast Cancer
In reclutamentoVolontari sani benvenuti
- Stanford University School of Medicine, Stanford · a 5 mi di distanza
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
In reclutamentoStudio osservazionale
- Stanford University School of Medicine, Stanford · a 5 mi di distanza
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
In reclutamentoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · a 5 mi di distanza
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi di distanza
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
In reclutamentoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi di distanza
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
In reclutamento
- Stanford University, Stanford · a 5 mi di distanza
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
In reclutamentoStudio osservazionale
- Stanford Cancer Institute, Palo Alto · a 5 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Stanford · a 5 mi di distanza
Studi su Cancro al seno in altre città
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Altri studi a Mountain View
- Cancro (tutti i tipi)40 studi
- Cancro metastatico25 studi
- Cancro del polmone non a piccole cellule21 studi
- Leucemia mieloide acuta19 studi
- Cancro ovarico19 studi
- Disturbo dello spettro autistico17 studi
- Cancro ai polmoni17 studi
- Cancro alla prostata15 studi
- Insufficienza cardiaca15 studi
- Autismo13 studi
- Leucemia linfoblastica acuta13 studi
- Cancro colorettale13 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.